Pancreatic Cancer Clinical Trials
Pancreatic Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for pancreatic Cancer. Corterve aggregates actively recruiting Pancreatic Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Pancreatic Cancer studies
- PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)NCT06673017PHASE1PanTher TherapeuticsPancreatic Ductal AdenocarcinomaNewport Beach, California
- OMO-103 for the Treatment of Locally Advanced or Metastatic Pancreatic Ductal AdenocarcinomaNCT07089940EARLY_PHASE1OHSU Knight Cancer InstituteLocally Advanced Pancreatic Ductal AdenocarcinomaPortland, Oregon
- A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas CancerNCT05604560PHASE2Lei ZhengPancreatic CancerBaltimore, Maryland
- Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic CancerNCT04172532PHASE1, PHASE2National Cancer Institute (NCI)Locally Advanced Pancreatic AdenocarcinomaDuarte, California
- Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic CancerNCT01174121PHASE2National Cancer Institute (NCI)Metastatic Colorectal CancerBethesda, Maryland
- A Phase II Study Evaluating BMS-986504 in MTAP-deleted Pancreatic CancerNCT07283705PHASE2M.D. Anderson Cancer CenterPhase 2 StudyHouston, Texas
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaNCT07562152PHASE3Immuneering CorporationPancreatic CancerHuntsville, Alabama
- Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsNCT04751435NAMemorial Sloan Kettering Cancer CenterEducational Materials for Genetic TestingBrooklyn, New York
- Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaNCT07491445PHASE3Revolution Medicines, Inc.Pancreatic CancerPhoenix, Arizona
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionNCT05334069Alliance for Clinical Trials in OncologyAcute Lymphoblastic LeukemiaAnchorage, Alaska
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsNCT06465069PHASE1Eli Lilly and CompanyMetastatic Solid TumorDuarte, California
- Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ AdenocarcinomaNCT07529808PHASE1, PHASE2BigHat Biosciences, Inc.Gastric CancerDuarte, California
Pancreatic Cancer trials by state
Pancreatic Cancer trials by metro
Frequently asked questions
- How do I find recruiting Pancreatic Cancer clinical trials?
- Browse the actively recruiting Pancreatic Cancer studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Pancreatic Cancer clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Pancreatic Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.